Aspiring can lower risk of breast cancer

Regular use of low-dose of aspirin can reduce the risk of breast cancer by 20 percent.

Researchers discovered a protective link between low-dose of aspirin and breast cancer," said lead author Christina A. Clarke, Ph.D., M.P.H., from the Cancer Prevention Institute of California.

Aspiring is a weak aromatase inhibitor, breast cancer is treated with stronger aromatase inhibitors since they reduce the amount of estrogen postmenopausal.

 Aromatase  reduces the development of cancer, improves cancer treatment and reduces the risk of cancer development.
 Researchers analyzed data recorded in questionnaires submitted by 57,164 women in the California's Teacher's Study.

In 2005, participants answered questions regarding family history of cancer and other conditions like use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDS) and other necessary conditions. Before 2013, 1,457 of these participants developed invasive breast cancer.